Marie Robin

A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality

Margaret L. MacMillan, Marie Robin, Andrew C. Harris et al. · Biology of Blood and Marrow Transplantation · 2015 · 272 citations · Full text

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)

Nicolaus Kröger, Simona Iacobelli, Georg‐Nikolaus Franke et al. · Journal of Clinical Oncology · 2017 · 238 citations · Full text

Cell Therapy, Immunology, Myeloid Neoplasia +16

Long-term outcome after bone marrow transplantation for severe aplastic anemia

Lionel Adès, Jean–Yves Mary, Marie Robin et al. · Blood · 2003 · 211 citations · Full text

Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

Gandhi Damaj, Alain Duhamel, Marie Robin et al. · Journal of Clinical Oncology · 2012 · 204 citations · Full text

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Nico Gagelmann, Markus Ditschkowski, Rashit Bogdanov et al. · Blood · 2019 · 175 citations · Full text